一种无形葡萄糖样-1受体的三维原子层结构
Daria Torodii1, Manuel Cordova1,2, Jacob B Holmes1,2
1Institut des Sciences et Ingénierie Chimiques, École Polytechnique Fédérale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland.
研究人员使用NMR结晶学来确定无形葡萄糖样-1受体 (GLP-1R) 激活剂的原子结构. 这为稳定无形药物配方提供了洞察力,以提高溶解度和药物输送.
科学领域:
- 制药科学
- 生物物理
- 结构生物学
背景情况:
- 无形配方增强药物溶解性,但很难在原子水平上进行表征.
- 了解原子结构对于开发稳定的无形药物至关重要.
研究的目的:
- 确定无形葡萄糖类-1受体 (GLP-1R) 激动剂的完整原子层结构.
- 找出对无形形态的稳定性负责的结构图案.
主要方法:
- 使用化学转移驱动的核磁共振 (NMR) 晶体学.
- 由碳和原子的化学转移分布来确定结构.
主要成果:
- 提供了详细的原子级构造和相互作用.
- 确定了关键的稳定结构动机,包括促进碳酸质子的键.
- 观察到两种有利于稳定的二醇环的方向.
- 发现含水可以稳定碳酸组.
结论:
- 对于无形药物结构的原子级特征,NMR晶体学是有效的.
- 对于无形GLP-1R激动剂的稳定,特定的键和环定向至关重要.
- 含水是提高无形配方稳定性的潜在策略.
更多相关视频
09:09Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography
Published on: September 20, 2016
18:45Harvesting and Cryo-cooling Crystals of Membrane Proteins Grown in Lipidic Mesophases for Structure Determination by Macromolecular Crystallography
Published on: September 2, 2012
相关概念视频
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Fischer Projections
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with...
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Protein and Protein Structure
A protein's shape is critical to its function. For example, an enzyme...
